A Molecular Model for the Mechanism of Acquired Tamoxifen Resistance in Breast Cancer

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2014.08.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

Oxidative Stress Contributes to the Tamoxifen-Induced Killing of Breast Cancer Cells: Implications for Tamoxifen Therapy and Resistance

Scientific Reports
Multidisciplinary
2016English

Role of Dynein Light Chain 1 in Tamoxifen Resistance in Breast Cancer

2007English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Acquired Resistance to Selective Estrogen Receptor Modulators (SERMs) in Clinical Practice (Tamoxifen & Raloxifene) by Selection Pressure in Breast Cancer Cell Populations

Steroids
Organic ChemistryMolecular BiologyPharmacologyBiochemistryEndocrinologyClinical Biochemistry
2014English

Selective Recruitment of Breast Cancer Anti-Estrogen Resistance Genes and Relevance for Breast Cancer Progression and Tamoxifen Therapy Response

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2010English

LAMP3 Is Involved in Tamoxifen Resistance in Breast Cancer Cells Through the Modulation of Autophagy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy